Literature DB >> 22646270

Lymphovascular invasion in micropapillary urothelial carcinoma: a study of 22 cases.

Elizabeth McQuitty1, Jae Y Ro, Luan D Truong, Steven S Shen, Qihui Zhai, Alberto G Ayala.   

Abstract

CONTEXT: Micropapillary urothelial carcinoma (MPUC) is a known aggressive variant of urothelial carcinoma. However, the reasons for its aggressiveness remain unclear.
OBJECTIVE: To investigate the frequency of lymphovascular invasion in 22 cases of MPUC.
DESIGN: Consecutive tissue sections were stained with D2-40 and CD34 to highlight lymphovascular channels associated with MPUC. Spaces containing tumor cells were scored as positive for lymphovascular invasion if the staining pattern on immunohistochemistry was distinct and circumferential.
RESULTS: Of 22 cases, 21 (95%) had lymphovascular invasion on immunohistochemical staining, with 91% lymphatic invasion and 4% vascular invasion. Interestingly, 8 cases were originally signed out as negative for lymphovascular invasion on the basis of hematoxylin-eosin-stained sections; of these, 7 (88%) had focal lymphovascular invasion evident on immunohistochemical staining.
CONCLUSIONS: Our results confirm that micropapillary lacunae are not lymphovascular channels. However, nearly all MPUC tumors (95% in this series) have evidence of lymphovascular invasion by immunohistochemical analysis. Our data support the use of micropapillary features as a morphologic marker for lymphovascular invasion and MPUC as an adverse histologic type of urothelial carcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22646270     DOI: 10.5858/arpa.2011-0463-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy.

Authors:  Simone Bertz; S Wach; H Taubert; R Merten; F S Krause; S Schick; O J Ott; E Weigert; O Dworak; C Rödel; R Fietkau; B Wullich; B Keck; A Hartmann
Journal:  Virchows Arch       Date:  2016-07-08       Impact factor: 4.064

2.  [Specific types of bladder cancer].

Authors:  S Bertz; A Hartmann; R Knüchel-Clarke; N T Gaisa
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

Review 3.  Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.

Authors:  Mahul B Amin; Steven C Smith; Victor E Reuter; Jonathan I Epstein; David J Grignon; Donna E Hansel; Oscar Lin; Jesse K McKenney; Rodolfo Montironi; Gladell P Paner; Hikmat A Al-Ahmadie; Ferran Algaba; Syed Ali; Isabel Alvarado-Cabrero; Lukas Bubendorf; Liang Cheng; John C Cheville; Glen Kristiansen; Richard J Cote; Brett Delahunt; John N Eble; Elizabeth M Genega; Christian Gulmann; Arndt Hartmann; Cord Langner; Antonio Lopez-Beltran; Cristina Magi-Galluzzi; Jorda Merce; George J Netto; Esther Oliva; Priya Rao; Jae Y Ro; John R Srigley; Satish K Tickoo; Toyonori Tsuzuki; Saleem A Umar; Theo Van der Kwast; Robert H Young; Mark S Soloway
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

4.  Micropapillary bladder cancer: a clinico-pathological characterization and treatment analysis.

Authors:  Z Li; H Liao; Z Tan; D Mao; Y Wu; Y M Xiao; S K Yang; L Zhong
Journal:  Clin Transl Oncol       Date:  2017-04-21       Impact factor: 3.405

5.  Utility of ERG Immunohistochemistry for Evaluation of Lymphovascular Invasion in Testicular Germ Cell Tumors: A Retrospective Pilot Study.

Authors:  Aaron M Udager; Jonathan B McHugh; Todd M Morgan; Daniel E Spratt; Arul M Chinnaiyan; Rohit Mehra
Journal:  Appl Immunohistochem Mol Morphol       Date:  2019 May/Jun

6.  Tumor cell invasion in blood vessels assessed by immunohistochemistry is related to decreased survival in patients with bladder cancer treated with radical cystectomy.

Authors:  Birgitte Carlsen; Tor Audun Klingen; Bettina Kulle Andreassen; Erik Skaaheim Haug
Journal:  Diagn Pathol       Date:  2021-11-22       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.